Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_assertion description "[In quadruple therapy, rabeprazole-based regimens had better efficacy than esomeprazole-based regimens. CYP2C19 polymorphism also played an important role in quadruple therapy. It seems advisable to change PPI to rabeprazole in second-line quadruple therap]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_assertion evidence source_evidence_literature NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_assertion SIO_000772 20633187 NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_assertion wasDerivedFrom gad-20150221 NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_assertion wasGeneratedBy ECO_0000203 NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.
- gad-20150221 importedOn "2015-02-21" NP181610.RAzgz4tVq0KqyyWlit2wVpLtYjtdq4cF6nHtm3mhAd4Us130_provenance.